YOUR BUSINESS AUTHORITY
Springfield, MO
Pfizer Inc. plans to spend more on research and development, according to The Wall Street Journal.
Officials with the New York City-based drugmaker raised the company’s projections for R&D spending to a range of $7.7 billion to $8.1 billion. That’s up from a previous forecast of $7.4 billion to $7.9 billion.
The company expects 25 to 30 new drugs from its pipeline will be approved through 2022.
Read more from The Wall Street Journal.
Project work in Springfield corridor will continue into 2031.